Scientific Publications

Search by Keyword(s)
Found 3 results

Filters: Author is Widlund, HR  [Clear All Filters]

Search Results

  • Showing 1-3 of 3 Results
2012
Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma.Jalili, A., Wagner C., Pashenkov M., Pathria G., Mertz KD, Widlund HR, Lupien M., Brunet JP, Golub T. R., Stingl G., Fisher DE, Ramaswamy S., and Wagner SN Journal of the National Cancer Institute, 2012/11/07, Volume 104, Issue 21, p.1673-9, (2012) Read More / View Supplemental Materials
Abstract
2005
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.Garraway, LA, Widlund HR, Rubin MA, Getz G., Berger AJ, Ramaswamy S., Beroukhim R., Milner DA, Granter SR, Du J., Lee C., Wagner SN, Li C., Golub T. R., Rimm DL, Meyerson ML, Fisher DE, and Sellers WR Nature, 2005/07/07, Volume 436, Issue 7047, p.117-22, (2005) Read More / View Supplemental Materials
Abstract
2004
Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.Du, J., Widlund HR, Horstmann MA, Ramaswamy S., Ross K., Huber WE, Nishimura EK, Golub T. R., and Fisher DE Cancer cell, 2004/12/01, Volume 6, Issue 6, p.565-76, (2004) Read More / View Supplemental Materials
Abstract
  • Showing 1-3 of 3 Results